![A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers | Nature Communications A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-020-20496-3/MediaObjects/41467_2020_20496_Fig1_HTML.png)
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers | Nature Communications
![Biological treatments in allergy: prescribing patterns and management of hypersensitivity reactions - The Journal of Allergy and Clinical Immunology: In Practice Biological treatments in allergy: prescribing patterns and management of hypersensitivity reactions - The Journal of Allergy and Clinical Immunology: In Practice](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/183a244c-c39e-455c-8181-7b3a8eb0ff37/fx1_lrg.jpg)
Biological treatments in allergy: prescribing patterns and management of hypersensitivity reactions - The Journal of Allergy and Clinical Immunology: In Practice
![Frontiers | Ferroptosis Signaling and Regulators in Atherosclerosis | Cell and Developmental Biology Frontiers | Ferroptosis Signaling and Regulators in Atherosclerosis | Cell and Developmental Biology](https://www.frontiersin.org/files/Articles/809457/fcell-09-809457-HTML/image_m/fcell-09-809457-g001.jpg)
Frontiers | Ferroptosis Signaling and Regulators in Atherosclerosis | Cell and Developmental Biology
![Frontiers | Epidemiology of Corneal Neovascularization and Its Impact on Visual Acuity and Sensitivity: A 14-Year Retrospective Study | Medicine Frontiers | Epidemiology of Corneal Neovascularization and Its Impact on Visual Acuity and Sensitivity: A 14-Year Retrospective Study | Medicine](https://www.frontiersin.org/files/Articles/733538/fmed-08-733538-HTML/image_m/fmed-08-733538-g002.jpg)
Frontiers | Epidemiology of Corneal Neovascularization and Its Impact on Visual Acuity and Sensitivity: A 14-Year Retrospective Study | Medicine
![A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers | Nature Communications A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-020-20496-3/MediaObjects/41467_2020_20496_Fig1_HTML.png)
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers | Nature Communications
![Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial - The ... Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial - The ...](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/3385f8f4-4d20-4c33-beb5-5a603fcf977e/gr1.gif)